Inimex Pharmaceuticals (Canada)

Recent papers from Inimex Pharmaceuticals (Canada)

1. Development of a human RPE In vitro model with AMD-like features reveals blue light-induced modulation of the endocannabinoid systemBiochemical and Biophysical Research Communications · 2025
2. Improved Chemistry of myo‐Inositol: A New Synthetic Strategy to Protected 1‐Keto‐ and 1,2‐Keto‐InososesEuropean Journal of Organic Chemistry · 2025
3. Cannabinol modulates the endocannabinoid system and shows TRPV1‐mediated anti‐inflammatory properties in human keratinocytesBioFactors · 2024
4. A Suction Blister Model to Characterize Epidermal Wound Healing and Evaluate the Efficacy of the Topical Wound Healing Agent Inm-755 in Healthy VolunteersEuropean Journal of Pharmaceutical Sciences · 2024
5. Concept of Goods in Exchange Trading LawsDeleted Journal · 2024
6. Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment PeriodClinical Hematology International · 2023
7. Rare Phytocannabinoids Exert Anti-Inflammatory Effects on Human Keratinocytes via the Endocannabinoid System and MAPK Signaling PathwayInternational Journal of Molecular Sciences · 2023
8. Real‐world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignanciesMycoses · 2022
9. Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human KeratinocytesInternational Journal of Molecular Sciences · 2022
10. Tetrodotoxin for Chemotherapy-Induced Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Finding TrialToxins · 2021
11. Safety, Tolerability, Pharmacokinetics, and Concentration-QTc Analysis of Tetrodotoxin: A Randomized, Dose Escalation Study in Healthy AdultsToxins · 2020
12. Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B CellsClinical Cancer Research · 2019
13. Mitochondria: the indispensable players in innate immunity and guardians of the inflammatory responseJournal of Cell Communication and Signaling · 2019
14. A stimulus-responsive, in situ-forming, nanoparticle-laden hydrogel for ocular drug deliveryDrug Delivery and Translational Research · 2018
15. Delta‐9‐tetrahydrocannabinol decreases masticatory muscle sensitization in female rats through peripheral cannabinoid receptor activationEuropean Journal of Pain · 2017
16. AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosisBritish Journal of Pharmacology · 2017
17. Potential Therapeutic Targets in Energy Metabolism Pathways of Breast CancerCurrent Cancer Drug Targets · 2017
18. Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design TrialPain Research and Management · 2017
19. A novel approach for emerging and antibiotic resistant infections: Innate defense regulators as an agnostic therapyJournal of Biotechnology · 2016
20. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain SyndromeThe Journal of Urology · 2016